0
0 (0%)
Histogen Inc. [CNAT]
Source:
Company Overview
Histogen Inc is a clinical-stage therapeutics company focused on developing our proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 526-3100 |
| Industry | manufacturing |
| CEO | Steven J. Mento |
| Website | www.histogen.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-3.5 |
| Net Income | $-3.9 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | |
| Operating Margin | -70,500 |
| Profit as % of Revenues | |
| Profit as % of Assets | -0% |
| Profit as % of Stockholder Equity | -0.1% |
Management Effectiveness
| Return on Equity | -0.1% |
| Return on Assets | -0.1% |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $5.8 |
| Total Liabilities | $1.4 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
